» Articles » PMID: 38102860

Increased Mortality Among African American Patients with DRESS Syndrome Compared to White Patients

Overview
Journal Int J Dermatol
Specialty Dermatology
Date 2023 Dec 16
PMID 38102860
Authors
Affiliations
Soon will be listed here.
Citing Articles

Morbilliform Eruptions: Differentiating Low-Risk Drug Eruptions, Severe Cutaneous Adverse Reactions, Viral Eruptions, and Acute Graft-Versus-Host Disease.

Yan A, Madigan L, Korman A, Shearer S, Dulmage B, Patel T Am J Clin Dermatol. 2025; .

PMID: 39888589 DOI: 10.1007/s40257-025-00924-0.


A Dermatological Dilemma: The Importance of Recognizing Dermatologic Manifestations of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) in Skin of Color Patients.

Qadir N, Marsalisi C, Reddy A, Stachler L, Onteddu N Cureus. 2024; 16(7):e64061.

PMID: 39114221 PMC: 11305447. DOI: 10.7759/cureus.64061.

References
1.
Gravlee C . How race becomes biology: embodiment of social inequality. Am J Phys Anthropol. 2009; 139(1):47-57. DOI: 10.1002/ajpa.20983. View

2.
Chen Y, Chang C, Cho Y, Chiu H, Chu C . Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol. 2012; 68(3):459-65. DOI: 10.1016/j.jaad.2012.08.009. View

3.
Keller S, Lu N, Blumenthal K, Rai S, Yokose C, Choi J . Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis. 2018; 77(8):1187-1193. PMC: 6045437. DOI: 10.1136/annrheumdis-2017-212905. View

4.
Cardones A . Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Clin Dermatol. 2020; 38(6):702-711. DOI: 10.1016/j.clindermatol.2020.06.008. View